H2QJ59 (H2QJ59_PANTR) Pan troglodytes (Chimpanzee)

glutaminase UniProtKBInterProInteractive Modelling

669 aa; Sequence (Fasta) ; 2 identical sequences: Homo sapiens: O94925; Gorilla gorilla gorilla: G3SB67

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Multidomain structure of human kidney-type glutaminase(KGA/GLS) Heteromer
O94925;
137-643
99.804A;
Human glutaminase C (Y466W) with L-Gln and Pi, filamentous formhomo-12-mer139-525
99.7412×PO4; 12×GLN;
Crystal Structure of Human GAC in Complex with Glutamate and BPTEShomo-4-mer136-560
100.0GOL;04A;
Human glutaminase C (Y466W) with L-Gln, closed conformationhomo-4-mer134-546
99.76GLN;
Crystal Structure of Human GAC in Complex with Glutamatehomo-4-mer135-546
100.0GLU;
Human GLS in complex with compound 12homo-4-mer136-546
100.0R90;
Crystal structure of glutaminase C in complex with inhibitor CB-839homo-4-mer137-546
100.063J;
Crystal structure of human GAC in complex with inhibitor UPGL00013homo-4-mer137-546
99.76Q94;
Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[…homo-4-mer137-546
1005XZ;
Crystal structure of human GAC in complex with inhibitor UPGL_00009: 2-phenyl-~{N}-[5-[[(3~{R})-1-[…homo-4-mer137-546
1005XX;
Crystal structure of human GAC in complex with inhibitor UPGL00023homo-4-mer137-546
100Q9M;
Crystal structure of human GAC in complex with inhibitor UPGL_00011: 2-phenyl-~{N}-[5-[[(3~{S})-1-[…homo-4-mer137-546
1005XY;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76QAM;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76QAA;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
100QAJ;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76U27;
Room temperature serial crystal structure of Glutaminase C in complex with inhibitor UPGL-00004homo-4-mer137-546
100.0B4A;
Human glutaminase C (Y466W) with L-Gln, open conformationhomo-4-mer137-546
99.75GLN;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76QAJ;
Crystal structure of human GAC in complex with inhibitor UPGL00018homo-4-mer137-546
99.75Q9S;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76QA4;
Crystal structure of human glutaminase C in complex with the inhibitor UPGL-00019homo-4-mer137-546
99.7669V;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76Q9V;
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
99.76Q9A;
Crystal Structure of human glutaminase with macrocyclic inhibitorhomo-4-mer137-546
100EN3;
Crystal structure of full length human glutaminase C expressed in E.colihomo-4-mer138-546
99.74
Room temperature serial crystal structure of Glutaminase C in complex with inhibitor BPTEShomo-4-mer137-545
100.004A;
Crystal structure of glutaminase C in complex with compound 27homo-4-mer138-545
100.0V4I;
Crystal structure of glutaminase C in complex with compound 11homo-4-mer138-544
100.0V59;
Filament structure of GAC with phosphatehomo-4-mer138-532
100PO4;
Filament interface structure of GAC with phosphatehomo-4-mer138-532
100PO4;
Crystal structure of human glutaminase in apo formhomo-4-mer221-533
100SO4;
Human GLS in complex with compound 3homo-4-mer222-532
100.036×SO4;04A;
Crystal structure of human glutaminase in complex with L-glutamate and BPTEShomo-4-mer221-531
10004A;GLU;SO4;
Crystal structure of human glutaminase in complex DONhomo-4-mer221-531
100ONL;
Crystal structure of human glutaminase in complex with BPTEShomo-4-mer221-531
10004A;SO4;
Crystal structure of human glutaminase in complex with L-glutaminehomo-4-mer221-531
100.0GLN;SO4;
Crystal structure of human glutaminase in complex with inhibitor 4homo-4-mer221-531
100.0BP9;
Human GLS in complex with compound 27homo-4-mer222-532
10020×SO4;R0C;
Crystal structure of human glutaminase in complex with inhibitor 3homo-4-mer221-531
100.0BP8;SO4;
Crystal structure of human glutaminase in complex with inhibitor 2homo-4-mer221-531
100.0BP0;SO4;
Allosteric inhibition of Kidney Isoform of Glutaminasehomo-4-mer221-531
100.0ZBS;
Human GLS in complex with compound 18homo-4-mer222-532
100.020×SO4;5XX;
Near full length Kidney type Glutaminase in complex with 2,2-Dimethyl-2,3-Dihydrobenzo[a] Phenanthr…homo-2-mer136-644
100.0HZO;
Crystal structure of glutaminase C in complex with inhibitor 2-phenyl-N-{5-[4-({5-[(phenylacetyl)am…homo-2-mer137-546
99.76B4A;
Crystal structure of human glutaminase in complex with L-glutamatehomo-2-mer222-531
100.0SO4;GLU;GOL;
C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - tetragonal crystal formhomo-2-mer553-645
100CL;NA;
C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - monoclinic crystal formhomo-2-mer553-642
100NA;
Allosteric inhibition of Kidney Isoform of Glutaminasemonomer221-531
100.063J;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8gwr.1.Ahomo-2-mer0.82136-644
HZO;100.00